Economic costs of childhood lead exposure in low- and middle-income countries
- PMID: 23797342
- PMCID: PMC3764081
- DOI: 10.1289/ehp.1206424
Economic costs of childhood lead exposure in low- and middle-income countries
Abstract
Background: Children's blood lead levels have declined worldwide, especially after the removal of lead in gasoline. However, significant exposure remains, particularly in low- and middle-income countries. To date, there have been no global estimates of the costs related to lead exposure in children in developing countries.
Objective: Our main aim was to estimate the economic costs attributable to childhood lead exposure in low- and middle-income countries.
Methods: We developed a regression model to estimate mean blood lead levels in our population of interest, represented by each 1-year cohort of children < 5 years of age. We used an environmentally attributable fraction model to estimate lead-attributable economic costs and limited our analysis to the neurodevelopmental impacts of lead, assessed as decrements in IQ points. Our main outcome was lost lifetime economic productivity due to early childhood exposure.
Results: We estimated a total cost of $977 billions of international dollars in low- and middle-income countries, with economic losses equal to $134.7 billion in Africa [4.03% of gross domestic product (GDP)], $142.3 billion in Latin America and the Caribbean (2.04% of GDP), and $699.9 billion in Asia (1.88% of GDP). Our sensitivity analysis indicates a total economic loss in the range of $728.6-1162.5 billion.
Conclusions: We estimated that, in low- and middle-income countries, the burden associated with childhood lead exposure amounts to 1.20% of world GDP in 2011. For comparison, in the United States and Europe lead-attributable economic costs have been estimated at $50.9 and $55 billion, respectively, suggesting that the largest burden of lead exposure is now borne by low- and middle-income countries.
Conflict of interest statement
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
The authors declare they have no actual or potential competing financial interests.
Comment in
-
Cleaning up pollutants to protect future health.Nature. 2018 Mar 8;555(7695):S20-S22. doi: 10.1038/d41586-018-02481-5. Nature. 2018. PMID: 29517021 No abstract available.
References
-
- Agency for Toxic Substances and Disease Registry. Toxicological Profile for Lead. Atlanta, GA:Agency for Toxic Substances and Disease Registry. 2007. Available: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=96&tid=22 [accessed 2 July 2012]
-
- Bellinger DC. What is an adverse effect? A possible resolution of clinical and epidemiological perspectives on neurobehavioral toxicity. Environ Res. 2004;95(3):394–405. - PubMed
-
- Centers for Disease Control and Prevention. Blood Lead Levels in Children. 2012. Available: http://www.cdc.gov/nceh/lead/ACCLPP/Lead_Levels_in_Children_Fact_Sheet.pdf [accessed 2 July 2012]
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases